tiprankstipranks
Trending News
More News >
Harbor BioSciences Inc (HRBR)
OTHER OTC:HRBR
US Market

Harbor BioSciences (HRBR) Ratios

Compare
19 Followers

Harbor BioSciences Ratios

HRBR's free cash flow for Q3 2024 was $-0.04. For the 2024 fiscal year, HRBR's free cash flow was decreased by $ and operating cash flow was $-0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
4.40 4.40 3.88 2.16 2.10
Quick Ratio
4.24 4.24 3.81 2.10 2.01
Cash Ratio
0.72 0.72 0.50 0.41 1.85
Solvency Ratio
0.23 0.23 0.46 0.65 0.30
Operating Cash Flow Ratio
-0.41 -0.41 0.68 1.05 1.04
Short-Term Operating Cash Flow Coverage
0.00 0.00 4.92 8.54 2.93
Net Current Asset Value
$ 68.00M$ 68.00M$ 118.02M$ 13.66M$ -72.88M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.05 0.20 0.22 0.36
Debt-to-Equity Ratio
0.07 0.07 0.31 0.40 0.99
Debt-to-Capital Ratio
0.06 0.06 0.24 0.29 0.50
Long-Term Debt-to-Capital Ratio
0.02 0.02 0.22 0.23 0.43
Financial Leverage Ratio
1.34 1.34 1.57 1.83 2.70
Debt Service Coverage Ratio
917.00 917.00 7.16 9.96 2.52
Interest Coverage Ratio
-2.46K -2.46K 18.62K 124.17 24.97
Debt to Market Cap
0.05 0.05 0.80 0.69 7.73
Interest Debt Per Share
0.28 0.28 1.65 1.63 2.36
Net Debt to EBITDA
-0.82 -0.82 0.54 0.35 -0.04
Profitability Margins
Gross Profit Margin
-7.79%-7.79%25.23%26.17%11.26%
EBIT Margin
-9.71%-9.71%19.89%48.02%23.64%
EBITDA Margin
5.22%5.22%28.68%58.06%37.61%
Operating Profit Margin
-18.51%-18.51%19.89%42.48%23.31%
Pretax Profit Margin
-9.71%-9.71%19.26%47.68%22.71%
Net Profit Margin
-8.02%-8.02%13.92%37.41%21.38%
Continuous Operations Profit Margin
-8.02%-8.02%13.92%37.41%21.38%
Net Income Per EBT
82.61%82.61%72.29%78.47%94.17%
EBT Per EBIT
52.48%52.48%96.84%112.25%97.40%
Return on Assets (ROA)
-6.76%-6.76%10.22%23.19%11.35%
Return on Equity (ROE)
-7.59%-9.05%16.00%42.34%30.65%
Return on Capital Employed (ROCE)
-17.78%-17.78%17.65%34.00%15.48%
Return on Invested Capital (ROIC)
-14.34%-14.34%12.21%25.35%13.32%
Return on Tangible Assets
-6.92%-6.92%10.36%23.50%11.52%
Earnings Yield
-24.86%-17.79%39.61%82.77%248.89%
Efficiency Ratios
Receivables Turnover
31.40 31.40 24.60 33.36 23.31
Payables Turnover
17.34 17.34 10.41 9.11 14.02
Inventory Turnover
44.64 44.64 45.86 35.15 27.80
Fixed Asset Turnover
2.31 2.31 2.43 1.73 1.18
Asset Turnover
0.84 0.84 0.73 0.62 0.53
Working Capital Turnover Ratio
1.38 1.38 1.91 2.73 3.64
Cash Conversion Cycle
-1.25 -1.25 -12.25 -18.73 2.75
Days of Sales Outstanding
11.63 11.63 14.84 10.94 15.66
Days of Inventory Outstanding
8.18 8.18 7.96 10.38 13.13
Days of Payables Outstanding
21.05 21.05 35.05 40.06 26.04
Operating Cycle
19.80 19.80 22.80 21.33 28.79
Cash Flow Ratios
Operating Cash Flow Per Share
-0.27 -0.27 0.97 1.73 1.33
Free Cash Flow Per Share
-0.37 -0.37 0.85 1.67 1.17
CapEx Per Share
0.10 0.10 0.12 0.07 0.16
Free Cash Flow to Operating Cash Flow
1.37 1.37 0.88 0.96 0.88
Dividend Paid and CapEx Coverage Ratio
-2.07 -2.07 7.14 21.27 7.70
Capital Expenditure Coverage Ratio
-2.68 -2.68 8.17 25.90 8.36
Operating Cash Flow Coverage Ratio
-0.98 -0.98 0.59 1.07 0.57
Operating Cash Flow to Sales Ratio
-0.06 -0.06 0.16 0.38 0.39
Free Cash Flow Yield
-19.36%-18.38%40.02%80.94%403.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-4.02 -5.62 2.52 1.21 0.40
Price-to-Sales (P/S) Ratio
0.43 0.45 0.35 0.45 0.09
Price-to-Book (P/B) Ratio
0.36 0.51 0.40 0.51 0.12
Price-to-Free Cash Flow (P/FCF) Ratio
-5.17 -5.44 2.50 1.24 0.25
Price-to-Operating Cash Flow Ratio
-5.35 -7.47 2.19 1.19 0.22
Price-to-Earnings Growth (PEG) Ratio
<0.01 0.04 -0.05 <0.01 >-0.01
Price-to-Fair Value
0.36 0.51 0.40 0.51 0.12
Enterprise Value Multiple
7.39 7.82 1.76 1.13 0.19
Enterprise Value
76.75M 81.30M 141.85M 162.58M 13.43M
EV to EBITDA
7.39 7.82 1.76 1.13 0.19
EV to Sales
0.39 0.41 0.51 0.66 0.07
EV to Free Cash Flow
-4.65 -4.92 3.59 1.79 0.21
EV to Operating Cash Flow
-6.38 -6.76 3.15 1.73 0.18
Tangible Book Value Per Share
3.89 3.89 5.16 3.93 2.27
Shareholders’ Equity Per Share
4.01 4.01 5.27 4.03 2.36
Tax and Other Ratios
Effective Tax Rate
0.17 0.17 0.28 0.22 0.06
Revenue Per Share
4.52 4.52 6.06 4.56 3.39
Net Income Per Share
-0.36 -0.36 0.84 1.71 0.72
Tax Burden
0.83 0.83 0.72 0.78 0.94
Interest Burden
1.00 1.00 0.97 0.99 0.96
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.02
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.75 0.75 1.15 1.02 1.84
Currency in USD